Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS)

NCT04278885 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Hereditary Autoinflammatory Disease

Interventions

DRUG: Lanadelumab

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]